DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
TAK-448 is an investigational drug.
There have been 346 clinical trials for TAK-448. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2018.
The most common disease conditions in clinical trials are Diabetes Mellitus, Hypertension, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Takeda, Millennium Pharmaceuticals, Inc., and National Cancer Institute (NCI).
Recent Clinical Trials for TAK-448
|A Study of TAK-994 in Adults With Narcolepsy||Takeda||Phase 2|
|Study to Evaluate Absorption, Metabolism, and Excretion, of TAK-994 in 6 Healthy Male Adults||Takeda||Phase 1|
|Bioavailability and Food Effect Study of Two Formulations of TAK-906||Takeda||Phase 1|